Business Case Studies, Strategy Case Study, Mergers, Acquisitions, Alliances and Synergies

print page
Tell A Friend
Bookmark

Mergers, Acquisitions, Alliances and Synergies Case Study

IBS CDC IBS CDC IBS CDC IBS CDC RSS Feed
Case Title:

Novartis' Acquisition of Aventis : The Potential Synergies

Publication Year : 2004

Authors: V. Bala Kiran, Sumit Kumar Chaudhuri

Industry: Pharmaceutical Manufacturers

Region: France

Case Code: MAA0018

Teaching Note: Not Available

Structured Assignment: Not Available


OR





Abstract:
After Aventis rejected the hostile takeover bid of Sanofi-Synthelabo on the grounds of financial inadequacy in January 2004, it approached Novartis, the Swiss drug manufacturer, to acquire it and save it from the potential acquisition. Although the Novartis-Aventis combination had the potential to form the second largest pharmaceutical company in the world with combined revenues of $47 billion, the French government was against the takeover of Aventis by a foreign company.

Pedagogical Objectives:

  • To discuss the probable synergies in case Aventis is acquired by Novartis.

Keywords : Ciba-Geigy;Mergers, Acquisitions, Alliances Case Study; Sandoz; Global pharmaceutical companies; Mergers and acquisitions; Sanofi-Synthelabo; Aventis; Novartis AG; Hostile takeovers; Hoechst AG; Prescription drugs; Rhone-Poulenc SA; Pfizer; Merk & Company; Anti-diabetic drugs; Anti-cancerous drugs

Related Links

Useful links

Currency Exchange Rates

Case Study :
   INR 200 = USD ($)

Structured Assignment:
   INR 150 = USD ($)

Teaching Note :
   INR 400 = USD ($)
c

Ad

Contact us: IBS Case Development Centre (IBSCDC), IFHE Campus, Donthanapally, Sankarapally Road, Hyderabad-500 082, Telangana, INDIA.
Mob: +91- 9640901313,
E-mail: casehelpdesk@ibsindia.org

©2020 - 25 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map xml sitemap